Join
Live feed
·
PRReleasevia Quantisnow
Bicycle Therapeutics plc logo

Bicycle Therapeutics Announces Interim BT8009 Phase I Clinical Trial Results Selected for an Oral Presentation at the 2022 AACR Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
BCYC· Bicycle Therapeutics plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCYC (Bicycle Therapeutics plc) and more on Quantisnow.